Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.41 -0.01 (-0.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Net Equity Issued and Repurchased (2015 - 2026)

Updated

Cartesian Therapeutics (RNAC) posted Net Equity Issued and Repurchased of $3.92 million for Q2 2026, compared with $85,000 a year earlier and down 74.6% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Cartesian Therapeutics was $19.36 million, down 84.1% year-over-year; for FY2025, it was $323,000, down 99.7% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -49.9% (FY2020 to FY2025).
  • In prior years, Cartesian Therapeutics' Net Equity Issued and Repurchased was $124.44 million in FY2024, $231,000 in FY2023 (+22.2%), $189,000 in FY2022 (-75.7%) and $778,000 in FY2021 (-92.4%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$36.67 million in Q4 2022 to a high of $121.56 million in Q3 2024 over five years.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $15.39 million (Q1 2026), $50,000 (Q4 2025) and $5,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Cartesian Therapeutics 188.59 Mn -346.18 Mn - 4.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.31 Mn
Mar 31, 2026 15.67 Mn
Dec 31, 2025 50,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 85,000.00
Mar 31, 2025 183,000.00
Dec 31, 2024 849,000.00
Sep 30, 2024 124.49 Mn
Jun 30, 2024 120,000.00
Mar 31, 2024 43.03 Mn
Dec 31, 2023 20.25 Mn
Sep 30, 2023 82,000.00
Mar 31, 2023 149,000.00
Sep 30, 2022 166,000.00
Jun 30, 2022 36.89 Mn
Mar 31, 2022 148,000.00
Dec 31, 2021 104,000.00
Sep 30, 2021 91,000.00
Jun 30, 2021 -20.56 Mn
Mar 31, 2021 21.31 Mn
API Access

Cartesian Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RNAC&period=max&api_key=YOUR_API_KEY